Clinical Trial Update: Left Ventricular Functional Changes of Uncontrolled Diabetes by Dapagliflozin Treatment Trial [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing left ventricular function changes in uncontrolled diabetes with dapagliflozin treatment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure Not Specified in Snippet Only Type 2 Diabetes Mellitus Is Confirmed
• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Mackay Memorial Hospital | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED